CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial

: J. Antonio Gutierrez, Gretchen M. Heizer, W. Schuyler Jones, Frank W. Rockhold, Kenneth W. Mahaffey, F. Gerry R. Fowkes, Jeffrey S. Berger, Iris Baumgartner, Peter Held, Brian G. Katona, Lars Norgren, Juuso I. Blomster, William R. Hiatt, Manesh R. Patel

Publisher: Elsevier

: 2020

: American Heart Journal

: American heart journal

: Am Heart J

: 229

: 118

: 120

: 3

: 0002-8703

: 1097-6744

DOI: https://doi.org/10.1016/j.ahj.2020.07.017